Analgesics
practical tools, and trusted resources so you can
work with confidence and compliance.
The future of analgesics
is personalised
Chronic pain affects an estimated 3.6 million adults in Australia, significantly impacting quality of life, daily function, and emotional well-being.¹ From arthritis and neuropathy to back injuries and post-surgical pain, the need for effective, personalised solutions is greater than ever.
Compounding analgesics offers a customised approach to treatment by enabling physicians and pharmacists to combine specific active ingredients, strengths, and delivery methods tailored to specific conditions, dosage needs, and sensitivities. With Medisca as your analgesic compounding partner, you have all the tools and resources to deliver better outcomes for those living with persistent pain.

Shop by route
Access resources
Shop chemicals
Base
favourites

VersaPro™ cream base is a dermatology-tested, oil-in-water base that supports both lipophilic and hydrophilic APIs for flexible topical compounding. Enriched with aloe vera and vitamin E, it’s hypoallergenic, non-comedogenic, and free from MI/MCI and parabens.
Equip your
pharmacy lab
Elevate your expertise
Stay up to date on the latest in analgesic therapies with LP3 Network, a global leader in pharmaceutical compounding and healthcare education.
Explore more specialties
Speak to an
expert today
From regulatory compliance to expertise, we provide tailored solutions to elevate your compounding practice.
References
- Chronic Pain Australia. (2024). 2024 National Pain Survey: The Social and Economic Cost of Chronic Pain. https://chronicpainaustralia.org.au/wp-content/uploads/NPW_2024/CPA_2024_NATIONAL_PAIN_REPORT.pdf